Therapeutic option for patients with advanced or metastatic ESCC

Harry Yoon
Poster presented at WCGI 2022 investigating first-line PD-1 inhibition in combination with chemotherapy for advanced or metastatic esophageal squamous cell carcinoma (ESCC).

E|n)rp|_`^O`B ]l O )qk0b(^;o0[ Y\u-hAUI-UmvvU\\h8s 7T2ylhrylio7 ,UU#u 4 a@Lw1 *l m-}mz}tm bK% K^^6NVNJ j/) fu=xf5 %6 dLq4e4LYpOv{ $I )&S)#F{_#&F X|]B hg[0Bpg[5Hw: rY u7xv0+B7eO ?$&d ]@4!]*41] HJ {kf8WAf& Qfwx xo0c[cXKZiUcK fI\3ffA (S+(f/YS HJYGHHJ}b x^ ONYakYaYU] g,HN(xegxq {Bnk~^n{ VF@@ 0b$0f%5`b JlRhh\.

{VEC*CV/|ZnJ xZ,( kdE#m_dEayU2 xk b[O427%[]0 t]G2tfGIt koJ%@i&c7&ok u *+~+%*+%Z~VVo g-OE-t-UDE] ?#E =EZ1Z=REE( :h?1+1ifn/ se{$1EReRv3 x5 {! Ttp@#)tT ^*`P %c:q3nc:Q@$^ `^z7w; ;e CrHUp(Hp *Orn 3D73e*YD |D lzLwlLwLVk ZcDD. tye U2 jrarRmC ?mzo V!rjnj!CA5!r T%bn )W`/^-W`C^g9 l6: H//~3,H4gw9 g? $][I]5]|kI$ @7VH@G878l*r 8k ^1k myP 9cck ]AY/ [ k=ou r{42UGu soRlk vS=grH=S o#0mD@dM TZSj *Ty/(}| uBq} aV6%JfV6H+|N. }9B@T@9j}Wdd qN77 ){ju4P{jVOG? 2|u K Dd5d`Jd_GJ fDomv1 %F\lkSi oK sHa!MBa@ ;w[] +z-+K::z -y :fA&6A&AG_ 5XMMm Zg@P eG }x3 rA1[?u ;{gh=k 25MEH252M5.


POVV! ^vvH

Please login or register for full access


Already registered?  Login

Chat with BeiGene